Amplification of mixed sequence nucleic acid fragments
AssigneeGenelabs Technologies, Inc.
InventorsKirk Fry, James Larrick, Albert Tam
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenelabs Technologies, Inc.
InventorsKirk Fry, James Larrick, Albert Tam
Estimating the term…
A method of amplifying a mixture of different-sequence DNA fragments which may be formed from RNA transcription, or derived from genomic single- or double-stranded DNA fragments. The fragments are treated with terminal deoxynucleotide transferase and a selected deoxynucleotide, to form a homopolymer tail at the 3' end of the anti-sense strands, and the sense strands are provided with a common 3'-end sequence. The fragments are mixed with a homopolymer primer which is homologous to the homopolymer tail of the anti-sense strands, and a defined-sequence primer which is homologous to the sense-strand common 3'-end sequence, with repeated cycles of fragment denaturation, annealing, and polymerization, to amplify the fragments. In one embodiment, the defined-sequence and homopolymer primers are the same, i.e., only one primer is used. The primers may contain selected restriction-site sequences, to provide directional restriction sites at the ends of the amplified fragments.
A method of amplifying a mixture of different-sequence double-stranded DNA fragments, comprising
A method of amplifying a mixture of different-sequence nucleic acid fragment strands, comprising
A method of preparing a mixture of single-stranded RNA fragments for cloning in a cloning vector, comprising
Dependencies are inferred from the claim text.